REG3A expression is enriched in an HCC molecular subtype marked by Wnt/β-catenin activation and CTNNB1 mutations, often linked to early-stage tumors and better prognosis [60,73]. The gene discussed is REG3A; the disease is hepatocellular carcinoma.